152 related articles for article (PubMed ID: 21863207)
1. Anxiety, psychosis and substance use: prevalence, correlates and recognition in an outpatient mental health setting.
Wyman KM; Chamberlain JA; Castle DJ
Afr J Psychiatry (Johannesbg); 2011 Jul; 14(3):218-24. PubMed ID: 21863207
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity Profiles of Psychotic Patients in Emergency Psychiatry.
Lecomte T; Giguère CÉ; Cloutier B; Potvin S;
J Dual Diagn; 2020; 16(2):260-270. PubMed ID: 31983294
[No Abstract] [Full Text] [Related]
3. Dose-response relationship between number of comorbid anxiety disorders in adolescent bipolar/unipolar disorders, and psychosis, suicidality, substance abuse and familiality.
Dilsaver SC; Akiskal HS; Akiskal KK; Benazzi F
J Affect Disord; 2006 Dec; 96(3):249-58. PubMed ID: 16904187
[TBL] [Abstract][Full Text] [Related]
4. Anxiety Symptoms in Psychotic Disorders: Results from the Second Australian National Mental Health Survey.
Bosanac P; Mancuso SG; Castle DJ
Clin Schizophr Relat Psychoses; 2016; 10(2):93-100. PubMed ID: 27440210
[TBL] [Abstract][Full Text] [Related]
5. Co-occurring mental illness, substance use disorders, and antisocial personality disorder among clients of forensic mental health services.
Ogloff JR; Talevski D; Lemphers A; Wood M; Simmons M
Psychiatr Rehabil J; 2015 Mar; 38(1):16-23. PubMed ID: 25799303
[TBL] [Abstract][Full Text] [Related]
6. The impact of co-occurring mood and anxiety disorders among substance-abusing youth.
Lubman DI; Allen NB; Rogers N; Cementon E; Bonomo Y
J Affect Disord; 2007 Nov; 103(1-3):105-12. PubMed ID: 17291589
[TBL] [Abstract][Full Text] [Related]
7. Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients.
Havassy BE; Arns PG
Psychiatr Serv; 1998 Jul; 49(7):935-40. PubMed ID: 9661229
[TBL] [Abstract][Full Text] [Related]
8. Associations between psychotic symptoms and substance use in young offenders.
Degenhardt L; Coffey C; Hearps S; Kinner SA; Borschmann R; Moran P; Patton G
Drug Alcohol Rev; 2015 Nov; 34(6):673-82. PubMed ID: 26084677
[TBL] [Abstract][Full Text] [Related]
9. Problem gambling and substance use in patients attending community mental health services.
Manning V; Dowling NA; Lee S; Rodda S; Garfield JBB; Volberg R; Kulkarni J; Lubman DI
J Behav Addict; 2017 Dec; 6(4):678-688. PubMed ID: 29254361
[TBL] [Abstract][Full Text] [Related]
10. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis.
Fusar-Poli P; Nelson B; Valmaggia L; Yung AR; McGuire PK
Schizophr Bull; 2014 Jan; 40(1):120-31. PubMed ID: 23180756
[TBL] [Abstract][Full Text] [Related]
11. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
[TBL] [Abstract][Full Text] [Related]
12. Predictors of psychosis remission in psychotic disorders that co-occur with substance use.
Caton CL; Hasin DS; Shrout PE; Drake RE; Dominguez B; Samet S; Schanzer B
Schizophr Bull; 2006 Oct; 32(4):618-25. PubMed ID: 16873441
[TBL] [Abstract][Full Text] [Related]
13. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Simon NM; Otto MW; Wisniewski SR; Fossey M; Sagduyu K; Frank E; Sachs GS; Nierenberg AA; Thase ME; Pollack MH
Am J Psychiatry; 2004 Dec; 161(12):2222-9. PubMed ID: 15569893
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of dual diagnosis among clinic attending patients in a de-addiction centre of a tertiary care hospital.
Subodh BN; Hazari N; Elwadhi D; Basu D
Asian J Psychiatr; 2017 Feb; 25():169-174. PubMed ID: 28262143
[TBL] [Abstract][Full Text] [Related]
15. Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries.
Salokangas RK; Ruhrmann S; von Reventlow HG; Heinimaa M; Svirskis T; From T; Luutonen S; Juckel G; Linszen D; Dingemans P; Birchwood M; Patterson P; Schultze-Lutter F; Klosterkötter J;
Schizophr Res; 2012 Jul; 138(2-3):192-7. PubMed ID: 22464922
[TBL] [Abstract][Full Text] [Related]
16. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and correlates of comorbidity 8 years after a first psychotic episode.
Farrelly S; Harris MG; Henry LP; Purcell R; Prosser A; Schwartz O; Jackson H; McGorry PD
Acta Psychiatr Scand; 2007 Jul; 116(1):62-70. PubMed ID: 17559602
[TBL] [Abstract][Full Text] [Related]
18. Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity--implications for diagnosis and ultra-high risk research.
Wigman JT; van Nierop M; Vollebergh WA; Lieb R; Beesdo-Baum K; Wittchen HU; van Os J
Schizophr Bull; 2012 Mar; 38(2):247-57. PubMed ID: 22258882
[TBL] [Abstract][Full Text] [Related]
19. Chronology of comorbid and principal syndromes in first-episode psychosis.
Strakowski SM; Keck PE; McElroy SL; Lonczak HS; West SA
Compr Psychiatry; 1995; 36(2):106-12. PubMed ID: 7758295
[TBL] [Abstract][Full Text] [Related]
20. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
